FDA backs prostate cancer drug Zytiga for earlier use | Reduction

FDA backs prostate cancer drug Zytiga for earlier use

Beware of Online Cancer Fraud by The U.S. Food and Drug Administration
License (according to Flickr): United States Government Work

Excerpt:

The agency said in a statement that Zytiga is now approved for late-stage prostate cancer patients who have not yet received chemotherapy, based on study results showing it can extend life by up to five months when taken by men in that group. The FDA previously approved the drug in April 2011 for men with prostate cancer who have already taken the chemotherapy drug docetaxel. Zytiga works by decreasing the male hormone testosterone. Testosterone stimulates the growth of prostate tumors, and treatment often includes drugs aimed at cutting the body's testosterone production. While older drugs can block about 90 percent of the hormone, scientists say Zytiga blocks virtually all of it, which can help slow the disease.

Concepts:

Cancer Testosterone Chemotherapy Oncology Prostate cancer Radiation therapy Metastasis Immune system

People:

Zytiga

Overall Sentiment: 0.084291

Relevance: 0.268675

Dr. Richard Pazdur

Overall Sentiment: 0.0587438

Relevance: 0.121889

Sentiment	Quote
0.25537	Dr. Richard Pazdur said the FDA's approval "provides patients and health care providers the option of using Zytiga earlier in the course of treatment."
Sentiment Stats:	Number of Quotes: 1 Aggregate Sentiment: 0.25537 Mean: 0.25537 Standard Deviation: 1.4142135623731

Key:

• Aggregate Sentiment is meant to be an indicator of an individual's overall sentiment.
• The Mean is meant to be an indicator of an individual's average comment sentiment.
• The Standard Deviation, when there are enough quotes, will indicate an individual's consistency of sentiment (i.e. a Standard Deviation of 0 would mean they were very consistent in their sentiment and 1 would mean they were very inconsistent).

Note that quote stats are likely to be meaningless beyond the aggregate score due to the tiny sample size. However, they are always provided just in case you find something useful there.

Additional Info:

HealthCondition: prostate cancer

Overall Sentiment: -0.0205218

Relevance: 0.907694

Technology: chemotherapy

Overall Sentiment: -0.247093

Relevance: 0.349195

Meta Tags Details

Source URL: http://feeds.cbsnews.com/~r/CBSNewsHealth/~3/SHsGN-ZNKVI/

Webpage Provided Desc:

FDA previously approved drug in April 2011 for men with prostate cancer who have already taken chemotherapy

Site Provided Title:

FDA backs prostate cancer drug Zytiga for earlier use

Provided Keywords:

• fda
• Food and Drug Administration
• hormones
• Prostate Cancer
• testosterone
• zytiga

Data Sources

Full Content: http://feeds.cbsnews.com/~r/CBSNewsHealth/~3/SHsGN-ZNKVI/

http://www.alchemyapi.com/